Deal lets Volcano add PAD device to its portfolio
Candace Stuart | May 28, 2014 | Cardiovascular Business | Vascular & Endovascular

Volcano will pay up to $130 million to acquire AtheroMed, giving Volcano access to a recently FDA-approved treatment for peripheral artery disease (PAD).

In January, AtheroMed received FDA clearance for its Phoenix Atherectomy System, a low-profile primary therapy for treating PAD. The technology uses an over-the wire system with a rotating, front-cutting element at the distal tip of a catheter that shaves diseased material into the catheter. The debulked material is continuously removed through an internal mechanism.

San Diego-based Volcano announced that it will pay $115 million in cash and an additional $15 million contingent on FDA approval of another Phoenix device before Nov. 15, 2014. Volcano is targeting the end of 2014 for a limited market release of Phoenix and a full market release in early 2015.

Manufacturing will shift from AtheroMed’s site in Menlo Park, Calif., to Volcano’s facility in Costa Rica in late 2015.

The acquisition is expected to be completed this quarter.

Candace Stuart, Contributor

Related Content

Boston Scientific recalls premixed embolic agent after two deaths
Anemia may help explain why women are more likely to die during heart bypass surgery
FDA grants anticoagulant its orphan drug designation for treating patients with implanted devices
FDA announces new recall of neurovascular catheters built by Johnson & Johnson subsidiary
GE Healthcare launching new AI software for handheld ultrasound system
New study provides ‘substantial evidence’ paclitaxel-coated devices are safe when treating lower-limb PAD

Around the web

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Radiology Business
Philips launches new AI-enabled CT scanner aimed at cardiology at ECR 2024

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Design by Adaptive Theme
Trimed Popup
Trimed Popup